The GSK3 signaling pathway is activated by cocaine and is critical for cocaine conditioned reward in mice

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Miller, Jonathan S ^a   Barr, Jeffrey L ^a   Harper, Lauren J ^a   Poole, Rachel L ^b   Gould, Thomas J ^b   Unterwald, Ellen M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN KINASE B; SERINE;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONED PLACE PREFERENCE TEST; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEAR; HABITUATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PROTEIN PHOSPHORYLATION; PUTAMEN; REWARD; SIGNAL TRANSDUCTION;

ANIMALS; COCAINE; CONDITIONING (PSYCHOLOGY); GLYCOGEN SYNTHASE KINASE 3; MALE; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION;

EID: 84895078111     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088026     Document Type: Article

References (57)

1. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, et al. (2005) An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122: 261-273. (Pubitemid 41032989)
2. Miller JS, Tallarida RJ, Unterwald EM (2009) Cocaine-induced hyperactivity and sensitization are dependent upon GSK3. Neuropharmacology 56: 1116-1123.
3. Xu C-M, Wang J, Wu P, Xue YX, Zhu WL, et al. (2011) Glycogen synthase kinase 3b in the nucleus accumbens core mediated cocaine-induced behavioral sensitization. J Neurochem 111: 1357-1368.
4. Enman NM, Unterwald EM (2012) Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse. Behav Brain Res 231: 217-225.
5. Russo SJ, Bolanos CA, Theobald DE, DeCarolis MA, Renthal W, et al. (2007) IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci 10: 93-99. (Pubitemid 46026532)
6. Marte BM, Downward J (1997) PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 22: 355-358.
7. Alessi D R, Andjelkovic M, Caudwell B, Cron P, Morrice N, et al. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15: 6541-6551. (Pubitemid 26413787)
8. Fayard E, Tintignac LA, Baudry A, Hemmings BA (2005) Protein kinase B/Akt at a glance. J Cell Sci 118: 5675-5678. (Pubitemid 43079259)
9. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789. (Pubitemid 26004411)
10. Embi N, Rylatt DB, Cohen P (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 107: 519-527.
11. Peineau S, Bradley C, Taghibiglou C, Doherty A, Bortolotto ZA, et al. (2008). The role of GSK-3 in synaptic plasticity. Br J Pharmacol 153 Suppl 1: S428-37. (Pubitemid 351341021)
12. Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93: 8455-9. (Pubitemid 26269579)
13. Jope RS, Roh MS (2006) Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets 7: 1421-1434. (Pubitemid 44718302)
14. Leroy K, Brion JP (1999) Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. J Chem Neuroanat 16: 279-293. (Pubitemid 29296952)
15. Grimes CA, Jope RS (2001) CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem 78: 1219-1232. (Pubitemid 32899754)
16. Shi X, McGinty JF (2011) D1 and D2 dopamine receptors differentially mediate the activation of phosphoproteins in the striatum of amphetamine-sensitized rats. Psychopharmacology 214: 653-663.
17. Beaulieu JM, Del'Guidice T, Sotnikova TD, Lemasson M, Gainetdinov RR (2011) Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors. Front Mol Neurosci 4: 1-13.
18. Beaulieu JM, Tirotta E, Sotnikova TD, Masri B, Salahpour A, et al. (2007) Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci 27: 881-885. (Pubitemid 46174508)
19. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, et al. (2004) Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 101: 5099-5104. (Pubitemid 38469209)
20. Perrine SA, Miller JM, Unterwald EM (2008) Cocaine regulates protein kinase B and glycogen synthase kinase-3 activity in selective regions of rat brain. J Neurochem 107: 570-577.
21. Shi X, McGinty JF (2007) Repeated amphetamine treatment increases phosphorylation of extracellular signal-regulated kinase, protein kinase B, and cyclase response element-binding protein in the rat striatum. J Neurochem 103: 706-713. (Pubitemid 47498014)
22. Hurd YL, Ungerstedt U (1989) Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse 3: 48-54. (Pubitemid 19042513)
23. Carboni E, Imperato A, Perezzani L, DiChiara G (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28: 653-661. (Pubitemid 19081023)
24. Moghaddam B, Bunney BS (1989) Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: comparison to amphetamine. Synapse 4: 156-161. (Pubitemid 19230123)
25. McKee BL, Meshul CK (2005) Time-dependent changes in extracellular glutamate in the rat dorsolateral striatum following a single cocaine injection. Neuroscience 133: 605-613.
26. McGinty JF, Shi XD, Schwendt M, Saylor A, Toda S (2008) Regulation of psychostimulant-induced signaling and gene expression in the striatum. J. Neurochem 104: 1440-1449. (Pubitemid 351316778)
27. Prinssen EP, Colpaert FC, Kleven MS, Koek W (2004) Ability of dopamine antagonists to inhibit the locomotor effects of cocaine in sensitized and non-sensitized C57BL/6 mice depends on the challenge dose. Psychopharmacology 172: 409-414. (Pubitemid 38650976)
28. Uzbay IT, Wallis CJ, Lal H, Forster MJ (2000) Effects of NMDA receptor blockers on cocaine-stimulated locomotor activity in mice. Behav Brain Res 108: 57-81.
29. Paxinos G, Franklin KBJ (2001) Academic Press, San Diego, CA.
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
31. Davis JA, Gould TJ (2006) The effects of DHBE and MLA on nicotine-induced enhancement of contextual fear conditioning in C57BL/6 mice. Psychopharmacology 184: 345-52. (Pubitemid 43255851)
32. Church WH, Justice JB Jr, Byrd LD (1987) Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine. Eur J Pharmacol 139: 345-348. (Pubitemid 17157328)
33. Heikkila RE, Orlansky H, Cohen G (1975) Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. Biochem Pharmacol 24: 847-852.
34. Kalivas PW, Duffy P (1995) D1 receptors modulate glutamate transmission in the ventral tegmental area. J Neurosci 15: 5379-5388.
35. 3 receptors. Mol. Pharmacology 79: 91-105.
36. Alimohamad H, Rajakumar N, Seah YH, Rushlow W (2005) Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum. Biol Psychiatry 57: 533-542. (Pubitemid 40311989)
37. Miller JS, Tallarida RJ, Unterwald EM (2010) Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice. Brain Res Bull 82: 184-187.
38. Brami-Cherrier K, Valjent E, Garcia M, Pages C, Hipskind RA, et al. (2002) Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation. J Neurosci 22: 8911-8921. (Pubitemid 35379061)
39. Wang HY, Undie AS, Friedman E (1995) Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Mol Pharmacol 48: 988-994.
40. Bergson C, Levenson R, Goldman-Rakic PS, Lidow MS (2003) Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling. Trends Pharmacol Sci 24: 486-492. (Pubitemid 37088174)
41. Fan G, Ballou LM, Lin RZ (2003) Phospholipase C-independent activation of glycogen synthase kinase-3beta and C-terminal Src kinase by Galphaq. J Biol Chem 278: 52432-52436. (Pubitemid 38035835)
42. Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattler S, et al. (2003). Diverse psychotomimetics act through a common signaling pathway. Science 302: 1412-1415. (Pubitemid 37452186)
43. Kim HS, Park WK, Jang CG and Oh S (1996) Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice. Brain Res Bull 40: 201-207.
44. Szatmari E, Habas A, Yang P, Zheng JJ, Hagg T, et al. (2005) A positive feedback loop between glycogen synthase kinase 3beta and protein phosphatase 1 after stimulation of NR2B NMDA receptors in forebrain neurons. J Biol Chem 280: 37526-37535. (Pubitemid 41642361)
45. Kim JJ, Rison RA, Fanselow MS (1993) Effects of amygdala, hippocampus, and periaqueductal gray lesions on short- and long-term contextual fear. Behav Neurosci 107: 1093-1098. (Pubitemid 24018220)
46. Phillips RG, LeDoux JE (1992) Differential contributions of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106: 274-285.
47. Longue SF, Paylor R, Wehner JM (1997) Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task. Behav Neurosci 111: 104-113. (Pubitemid 27097521)
48. Wei CJ, Augusto E, Gomes CA, Singer P, Wang Y, et al. (2013) Regulation of fear responses by striatal and extrastriatal adenosine A2A receptors in forebrain. Biol Psychiatry Jun 29 Epub ahead of print.
49. Pohlack ST, Nees F, Ruttorf M, Schad LR, Flor H (2012) Activations fo the ventral striatum during aversive contextual conditioning in humans. Biol Psychol 91: 74-80.
50. Ferreira TL, Shammah-Lagnado SJ, Bueno OF, Moreira KM, Fornari RV, et al. (2008) The indirect amygdala-dorsal striatum pathway mediates conditioned freezing: insights on emotional memory networks. Neuroscience 153: 84-94.
51. Cervo L, Samanin R (1995) Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res 673: 242-250.
52. Graham DL, Hoppenot R, Hendryx A, Self DW (2007) Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats. Psychopharmacology (Berl) 191: 719-730. (Pubitemid 46355876)
53. Self DW, Stein L (1992) The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res 582: 349-352.
54. Harris GC, Aston-Jones G (2003) Critical role for ventral tegmental glutamate in preference for a cocaine-conditioned environment. Neuropsychopharmacology 28: 73-76.
55. Heusner CL, Palmiter RD (2005) Expression of mutant NMDA receptors in dopamine D1 receptor-containing cells prevents cocaine sensitization and decreases cocaine preference. J Neurosci 25: 6651-6657. (Pubitemid 40995297)
56. Everitt BJ, Robbins TW (2013) From the ventral to the dorsal striatum: Devolving views of their roles in drug addiction. Neurosci Biobehav Rev; e-pub ahead of print 21 February 2013; doi: 10.1016/j.neubiorev.2013.02.010.
57. Lesscher HM, Vanderschuren LJ (2012) Compulsive drug use and its neural substrates. Rev Neurosci 18: 1-15.